Impact of Busulfan Exposure on Transplant Outcomes for Patients with Relapsed Multiple Myeloma Undergoing CD34-Selected Allogeneic Hematopoietic Stem Cell Transplant

被引：0
|
作者：
Lin, Andrew [1 ]
Drill, Esther [2 ]
Proli, Anthony J. [1 ]
Beyer, Kristen [1 ]
Bhatt, Valkal [1 ]
Devlin, Sean M. [2 ]
Koehne, Guenther [3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Pharm, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplant Serv, Dept Med, 1275 York Ave, New York, NY 10021 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 03期
关键词：
D O I：
10.1016/j.bbmt.2016.12.200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
395
引用
收藏
页码：S288 / S289
页数：2
相关论文
共 50 条
  • [1] Impact of Busulfan Exposure on Transplant Outcomes for Patients with Advanced Myelodysplastic Syndrome Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation
    Proli, Anthony J.
    Tamari, Roni
    Zheng, Junting
    Jakubowski, Ann A.
    Papadopoulos, Esperanza
    Ponce, Doris M.
    Devlin, Sean M.
    Sauter, Craig S.
    Perales, Miguel-Angel
    Young, James W.
    Giralt, Sergio A.
    Castro-Malaspina, Hugo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S348 - S348
  • [2] CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma
    Smith, Eric
    Devlin, Sean M.
    Kosuri, Satyajit
    Orlando, Evelyn
    Landau, Heather
    Lesokhin, Alex M.
    Chung, David J.
    Hassoun, Hani
    Lendvai, Nikoletta
    Landgren, Ola
    Giralt, Sergio
    Chari, Ajai
    Jagannath, Sundar
    Koehne, Guenther
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (02) : 258 - 267
  • [3] Outcome Predictors in CD34 Selected Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma
    Bryant, Adam
    Hilden, Patrick
    Maloy, Molly
    Perales, Miguel-Angel
    Koehne, Guenther
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S304 - S305
  • [4] Impact of Busulphan Exposure on Transplant Outcomes for Patients with Advanced Myelodysplastic Syndromes Undergoing CD34 Selected Allogeneic Hematopoietic Cell Transplantation
    Tamari, Roni
    Anthony, Proli
    Zheng, Juntig
    Jakubowski, Ann A.
    Papadopoulos, Esperanza B.
    Ponce, Doris M.
    Devlin, Sean
    Sauter, Craig S.
    Young, James W.
    Giralt, Sergio A.
    Castro-Malaspina, H. R.
    BLOOD, 2015, 126 (23)
  • [5] Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM)
    Ghosh, Arnab
    Nagel, Katherine
    Hosszu, Kinga
    Datta, Ambika
    Thompson, Christina
    Levia, Khayla
    Kamrowski, Alyssa
    McAvoy, Devin
    Chung, David
    Landau, Heather
    Scordo, Michael
    Giralt, Sergio
    Shah, Gunjan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S179 - S179
  • [6] Outcomes of Allogeneic Stem Cell Transplant for Multiple Myeloma
    Schmidt, Walker M.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Kumar, Shaji K.
    Dispenzieri, Angela
    Dingli, David
    Cook, Joselle
    Lacy, Martha Q.
    Kapoor, Prashant
    Leung, Nelson
    Muchtar, Eli
    Warsame, Rahma M.
    Kourelis, Taxiarchis
    Binder, Moritz
    Gonsalves, Wilson I.
    Gertz, Morie A.
    BLOOD, 2022, 140 : 7182 - 7184
  • [7] Trends and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma at Mayo Clinic
    Mir, Muhammad A.
    Kapoor, Prashant
    Kumar, Shaji
    Pandey, Shivlal
    Dispenzieri, Angela
    Lacy, Martha Q.
    Dingli, David
    Hogan, William
    Buadi, Francis
    Hayman, Suzanne
    Gandhi, Manish
    Gertz, Morie A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (06): : 349 - 357
  • [8] Outcomes after Autologous Stem Cell Transplant in Patients with Relapsed Multiple Myeloma
    Lemieux, Christopher
    Craig, Juliana
    Iberri, David
    Arai, Sally
    Johnston, Laura J.
    Lowsky, Robert
    Muffly, Lori S.
    Shiraz, Parveen
    Liedtke, Michaela
    Rezvani, Andrew R.
    Frank, Matthew J.
    Weng, Wen-Kai
    Meyer, Everett H.
    Shizuru, Judith A.
    Negrin, Robert S.
    Miklos, David B.
    Sidana, Surbhi
    BLOOD, 2020, 136
  • [9] The Impact of Peri-Transplant Antibiotic Exposure on Outcomes in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Alawdah, Laila
    Coyte, Katharine Z.
    Lehmann, Leslie E.
    Flett, Kelly
    Whangbo, Jennifer
    Rakoff-Nahoum, Seth
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S180 - S180
  • [10] Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant
    Pasvolsky, Oren
    Saliba, Rima M.
    Masood, Adeel
    Mohamedi, Ali H.
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Ramdial, Jeremy
    Nieto, Yago
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (04) : E37 - E41
12345